Zonare Medical Systems raised $34 million in equity funding earlier this month to put toward the development of a next-generation ultrasound platform. The company's Zone Sonography technology is being groomed first for general imaging and ob/gyn.
Zonare Medical Systems raised $34 million in equity funding earlier this month to put toward the development of a next-generation ultrasound platform. The company's Zone Sonography technology is being groomed first for general imaging and ob/gyn. Subsequent developments will address cardiology and 4D imaging. Previous and new investors include Montagu Newhall Associates, Kaiser Permanente Ventures, Earlybird Venture Capital, and Siemens Venture Capital.
The company is being directed by new president and CEO Donald J. Southard, who joined the firm last month after serving as president of Datascope's $160 million patient monitoring business.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.